Navigation Links
Prime Therapeutics Vice President of Specialty Pharmacy Solutions Speaks at 16th Annual PBMI Drug Benefit Conference
Date:2/16/2011

PHOENIX, Feb. 16, 2011 /PRNewswire/ -- Spending on specialty medications is growing rapidly, but helping patients remain adherent to these important medications can help slow disease progression and keep patients out of the hospital, Prime Therapeutics Vice President of Specialty Pharmacy Solutions Elizabeth Mauer told participants at the 16th Annual Pharmacy Benefit Management Institute (PBMI) Drug Benefit Conference today.

"Balancing the tremendous financial burden of these drugs with their proven ability to improve health and save lives is a significant challenge for both members and plan sponsors," said Mauer. "Greater competition, new tools for specialty management, improved understanding of the cost/quality equation, a greater focus on patient outcomes and improved coordination across the health care spectrum will all change how we manage specialty benefits in the years ahead."

Specialty pharmaceuticals treat complex or chronic illnesses such as multiple sclerosis, hemophilia, hepatitis C and rheumatoid arthritis – conditions for which adherence to medications is critical. Many of these medications are "biologic" drugs, requiring a complex production process. Spending on specialty medications is increasing at twice the rate of the overall drug market, reaching an average annual cost of $32,735 in 2009.(i)

Mauer also spoke about the forces driving growth of specialty spending and identified the four keys for effective specialty pharmacy management: distribution channel, utilization management, care management and contracting activities.

"Through Prime's Triessent program, we found that safe and efficient delivery of medications, education and guidance from clinicians helps patients manage both their benefits and their condition," said Mauer. "Our integrated approach to pharmacy and medical care helps patients better adhere to their treatment plan. That means better health, fewer hospitalizations and less chance of needing ad
'/>"/>

SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum
2. Greenways PrimeSUITE EHR Featured at IHE North America Connectathon
3. Greenways PrimeSUITE Endorsed by Allina Hospitals & Clinics
4. Prime Healthcare Converts System-Wide to Masimo rainbow SET Technology
5. Columbia University Students Learn About Pharmacy Benefit Management From Prime Therapeutics President and CEO
6. Prime Therapeutics Receives 2011 TIPPS Certification
7. Greenways PrimeSUITE Receives ONC-ATCB 2011/2012 Certification
8. Prime Therapeutics Announces URAC Accreditation
9. Prime Therapeutics Hires Peter Wickersham, Senior Vice President Cost of Care
10. Massachusetts Regional Extension Center Selects Greenways PrimeSuite
11. Nigerian Association of Pharmacists and Pharmaceutical Scientists in America (NAPPSA) Announces Prime Vendor Agreement with H. D. Smith
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces ... is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
(Date:1/14/2014)... HAMILTON, N.J. , Jan. 14, 2014 InformEx, ... buyers and sellers of high-value chemistry, will hold the 30 ... Miami Beach Convention Center from January 21-24. ... than 3,500 attendees from top pharmaceutical, fine chemical and specialty ...
(Date:1/14/2014)... , Jan. 14, 2014   NuAire , a manufacturer of ... agreement with Hitachi Koki of Japan ... North America . NuAire will utilize its network ... and Canada to offer assistance in application ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... 26, 2007 /PRNewswire-FirstCall/ --,Replidyne, Inc. today announced ... a novel topical antibiotic that has shown ... including,methicillin-resistant S. aureus (MRSA). The results of ... REP8839 appears safe,well-tolerated and associated with low ...
... in a randomized phase II/III clinical trial,anticipated ... /PRNewswire-FirstCall/ -- Cell,Therapeutics, Inc. (CTI) announced the ... with pixantrone (BBR,2778) resulted in minimal or ... significant cardiac damage.,The studies compared the cardiac ...
Cached Medicine Technology:Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 2Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 3Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 2Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 3Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 5Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 6
(Date:4/24/2014)... On April 28, the Center for BrainHealth will ... our most pressing brain-related challenges at its inaugural ... Resilience and Regeneration." Featured speakers will include Dr. ... the Center for BrainHealth, U.S. Senator Chuck Grassley ... Doggett, Deputy Assistant Secretary for Policy and Early ...
(Date:4/24/2014)... more than one out of three survivors of ... in The Lancet Respiratory Medicine , and ... rather than mentally. , It is one of ... and functional outcomes of critical care survivors, according ... of Medicine, and it highlights a significant public ...
(Date:4/24/2014)... Foundation has awarded LSU Health Sciences Center New ... grant in the amount of $295,635. The funding ... social and educational backgrounds, underrepresented in the sciences, ... project will provide students with training for 10 ... will be led by Principal Investigator Dr. Fern ...
(Date:4/23/2014)... 24, 2014 Pregnant immigrants from Sub-Saharan Africa, ... monitoring during pregnancy, according to new research from ... in the British Journal of Obstetrics and ... eclampsia rates among immigrants and native-born women in ... Denmark, Sweden, Spain (Catalonia and Valencia) and the ...
(Date:4/23/2014)... April 23, 2014 The American Society for Radiation ... Role of Postoperative Radiation Therapy for Endometrial Cancer: ... of adjuvant radiation therapy in the treatment of ... in the May-June 2014 issue of Practical ... journal of ASTRO. The full-length guideline is available ...
Breaking Medicine News(10 mins):Health News:Inaugural Brain Health Summit focuses on brain resilience and regeneration 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Pregnancy complications may be more common in immigrants from certain regions 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3
... are readmitted within a year, study finds , , WEDNESDAY, ... patients discharged from the hospital is readmitted within 30 ... within a year, a new study finds. , The ... problem that researchers believe could be prevented through better ...
... Extreme Physical Performance (EP2), a sport supplement firm, has ... that manufactures a new generation of safe and effective ... human physical performance. Together, they will bring innovative new ... gym goers. TORABOLIC is Indus,s first new novel ingredient ...
... YORK, April 1 Spring may be synonymous ... for Alex Mele of Coram, NY, a 15-year-old baseball player ... a fight to shut out cancer.Mele, a catcher and third ... Junior Varsity Baseball Team, suddenly fell ill last November. ...
... SAN DIEGO, April 1 Gen-Probe (Nasdaq: ... its co-respondents F. Hoffmann-La Roche Ltd. and Roche Molecular ... (now Qiagen) concerning the Company,s supply and purchase agreement ... , Earlier today, a three-member arbitration panel ...
... Touch(TM) hearing aid is smallest receiver-in-canal product availableSALT LAKE ... SNCI ) will celebrate its first receiver-in-canal ("RIC") ... be held in Dallas, Texas, April 2 through 4, ... is the smallest receiver-in-canal product available in the market. ...
... 1 Novavax Inc. (Nasdaq: NVAX) announced ... of 12.5 million shares of Novavax,s common stock at $0.88 per ... of the new strategic alliance between Novavax and Cadila. Novavax intends ... to pay a portion of its 4.75% senior convertible notes due ...
Cached Medicine News:Health News:High Rate of Rehospitalizations Costing Billions 2Health News:High Rate of Rehospitalizations Costing Billions 3Health News:New Sports Supplement Company to Partner with Indus Biotech 2Health News:Blood, Marrow Drive Offers Hope for Baseball Player, 15 2Health News:Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement 2Health News:Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement 3Health News:Sonic Innovations Celebrates Company's First Receiver-In-Canal Hearing Aid 2Health News:Sonic Innovations Celebrates Company's First Receiver-In-Canal Hearing Aid 3Health News:Novavax Announces Closing of $11 Million Common Stock Sale to Subsidiary of Cadila Pharmaceuticals 2
... proven to be a successful alternative ... knee arthroplasty with proper indications. The ... unicompartmental knee system developed to streamline ... latest conservative surgical techniques with the ...
... Knee CR system was designed to ... femoral joint has a recessed, deepened ... advancement of the patella, which has ... The anatomic groove promotes more normal ...
The Biopro Modular TKO implant is among the thinnest bone conserving Posterior Cruciate Ligament sparing knees available. It provides all the benefits of the Biopro TKO implant and gives the option o...
... PowerSuite™ holmium laser combines excellent cutting, ... virtually bloodless procedures. It is also ... gall bladder stones of all compositions, ... tool. Because its laser light is ...
Medicine Products: